In summary, our results suggest that inflammatory factors TNF-α and TGF-β enhance lung cancer stemness of H460 cells through NF-κB and FoxM1, and BrMC can inhibit those induced stemness through simultaneously inhibiting expression of NF-ĸB and FoxM1 (Fig. 7). Here, FOXM1 is linked to lung cancer.